A detailed history of Squarepoint Ops LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Squarepoint Ops LLC holds 69,400 shares of LEGN stock, worth $2.78 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
69,400
Previous 101,734 31.78%
Holding current value
$2.78 Million
Previous $5.71 Million 46.14%
% of portfolio
0.01%
Previous 0.01%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$39.5 - $57.22 $1.28 Million - $1.85 Million
-32,334 Reduced 31.78%
69,400 $3.07 Million
Q1 2024

May 15, 2024

BUY
$55.06 - $69.99 $24,391 - $31,005
443 Added 0.44%
101,734 $5.71 Million
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $2 Million - $2.44 Million
35,015 Added 52.83%
101,291 $6.09 Million
Q2 2023

Aug 14, 2023

BUY
$46.28 - $75.01 $2.08 Million - $3.37 Million
44,991 Added 211.37%
66,276 $4.58 Million
Q1 2023

May 15, 2023

BUY
$43.42 - $57.37 $91,051 - $120,304
2,097 Added 10.93%
21,285 $1.03 Million
Q4 2022

Feb 14, 2023

SELL
$38.8 - $55.46 $1.03 Million - $1.47 Million
-26,494 Reduced 58.0%
19,188 $957,000
Q3 2022

Nov 14, 2022

BUY
$38.15 - $57.1 $831,898 - $1.25 Million
21,806 Added 91.33%
45,682 $1.86 Million
Q2 2022

Aug 15, 2022

SELL
$33.54 - $55.0 $187,756 - $307,890
-5,598 Reduced 18.99%
23,876 $1.31 Million
Q1 2022

May 16, 2022

BUY
$31.02 - $48.18 $372,177 - $578,063
11,998 Added 68.65%
29,474 $1.07 Million
Q4 2021

Feb 14, 2022

BUY
$41.14 - $56.98 $718,962 - $995,782
17,476 New
17,476 $815,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.